If you cannot view this email properly, please go here. Newsletter 05/2018
Stem Cells—What’s All the Fuss About?

Potential; that’s what—big potential. Stem cells are undifferentiated. Biologically speaking, this means they are not yet specialised, not yet directed to a particular purpose. In other words, they have no job. But the brilliant bit is that they are capable of many different jobs—of differentiating into any number of different cell types.

And if their differentiation can be directed—if they can be given a ‘job’—then stem cells can be leveraged where they are needed most in the human body to treat and prevent disease. But it’s not a matter of ‘if’ anymore. Scientists have, indeed, already begun to do this, and stem cells are now being used by physicians to address wide-ranging health issues, from autoimmune diseases to cancers and many more in between.

But there’s one caveat to all this—and this is where part of the controversy lies. Stem cells can be sourced from either tissue (in various forms) or from a four- or five-day old embryo. In the former case, there is no adverse effect on the donor; in the latter, the result is the destruction of the embryo. For those who regard the embryo as life, its wilful termination will likely be a point of moral contention.

However, for those seeking orthopaedic stem cell treatment through Medical Travel, this is a non-issue. Our partner clinic, Cellthera, harvests stem cells only from fat and connective tissue. As a leader in stem cell research and application, they are intimately acquainted with the healing power of stem cells and have been harnessing it to help connective tissue disease sufferers since 2010. It is a power that can be summed up in one word: potential.

If you're interested in our services and keen to save
some money, go here for a €50 discount.
Faces of Medical Travel: Profile of the Month

Dr. Michálek is the founder of Cellthera, Ltd., a scientific research and development group focused on the regenerative use of adipose- and connective tissue-derived stem cells. He is a specialist in clinical oncology, paediatrics, allergology and clinical immunology, with 16 years of experience in regenerative medicine and cell therapy. The author of more than 200 scientific publications, Dr. Michálek is also president of the International Consortium for Cell Therapy and Immunotherapy (ICCTI), which organises conferences, workshops, and seminars to propagate innovative, cell-based treatment strategies throughout the world. He speaks English fluently.

Learn more about Dr. Michálek and Cellthera Clinic here.

Blog of the Month: ‘New Frontiers in Medicine’

Interested in learning more of stem cells, their potential, and their implications? This month’s blog highlight fits the bill. Enjoy.

Voices of Medical Travel: Testimonial of the Month

Go here to read more testimonials.

And that’s all for now. Remember to be on the lookout in your inbox, for next month’s issue.
info@medicaltravelczech.com +44 20 3286 8822
If you do not wish to receive messages from us any longer, please go here to unsubscribe.
© Medical Travel Czech Republic. All Rights Reserved, Design by XTEND London